Feasibility of Gallium-68-tilmanocept PET/CT for Sentinel Lymph Node Detection in Endometrial Cancer

Status:
Not yet recruiting

Trial end date:
2023-05-01

Target enrollment:

Participant gender:

This pilot study evaluates the feasibility of 68Ga-tilmanocept PET/CT for SLN mapping in patients with endometrial cancer.

Phase 3

UMC Utrecht